ReviewWorld journal of oncology2023

Folfirinox vs. Gemcitabine + Nab-Paclitaxel as the First-Line Treatment for Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Nooraldin Merza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.